B cell-based therapy produces antibodies that inhibit glioblastoma growth. - Wang S; Castro BA; Katz JL; Arrieta V; Najem H; Vazquez-Cervantes GI; Wan H; Olson IE; Hou D; Dapash M; Billingham LK; Chia TY; et al. (The Journal of clinical investigation, 2024)